Wandong medical reports progress on share repurchase for employee incentives

Beijing Wandong Medical Technology Co., Ltd. announced the latest progress on its share repurchase program as of October 9, 2025. The company has cumulatively repurchased 281,200 shares through centralized bidding, representing 0.04% of its total share capital. The highest price paid was yuan 17.99 per share, and the lowest was yuan 17.65 per share, with a total expenditure of yuan 4,998,291 (excluding transaction fees).

The share repurchase program, approved on August 22, 2025, aims to utilize company funds for an employee stock ownership plan or equity incentives. The planned repurchase amount ranges from yuan 30m to yuan 60m, with a maximum repurchase price not exceeding yuan 25 per share. The program is set to be implemented within 12 months from the approval date, specifically between August 22, 2025, and August 21, 2026.

The company stated that the repurchase aligns with relevant laws, regulations, and its approved repurchase plan. Beijing Wandong Medical Technology will continue to comply with regulatory requirements, disclosing further progress and potential risks to investors.